FDA authorizes Roche drug for severely ill COVID-19 patients
https://healthell.blogspot.com/2021/06/fda-authorizes-roche-drug-for-severely.html
FDA authorizes Roche drug for severely ill COVID-19 patients
The Food and Drug Administration granted emergency approval to Roche’s Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving oxygen and steroid medications.
